Velphoro (sucroferric oxyhydroxide)

pCPA File Number: 21089

Negotiation Status:

Concluded with an LOI

Indication(s):

Hyperphosphatemia, end-stage renal disease

Sponsor/Manufacturer:

Vifor Fresenius Medical Care Renal Pharma

CDA-AMC Project Number:

SR0571-000

pCPA Engagement Letter Issued:

2019-04-12

Negotiation Process Concluded:

2019-09-17